Our data demonstrated that the activity of HDAC especially HDAC3 is significantly reduced in RA PBMCs, which results in hyperacetylation of H3 histone, supporting the role of HAT as potential targets in RA. The gene discussed is HDAC3; the disease is rheumatoid arthritis.